Literature DB >> 23868126

Genome Sequences of Multidrug-Resistant Acinetobacter baumannii Strains from Nosocomial Outbreaks in Japan.

Masato Suzuki1, Mari Matsui, Satowa Suzuki, Emiko Rimbara, Satomi Asai, Hayato Miyachi, Tohru Takata, Yoichi Hiraki, Fumio Kawano, Keigo Shibayama.   

Abstract

Acinetobacter baumannii has emerged worldwide as an important nosocomial pathogen in medical institutions. Here, we present the draft genome sequences of A. baumannii strains MRY09-0642, MRY10-0558, and MRY12-0277 that were isolated from nosocomial outbreaks in Japan between 2008 and 2012 and that are resistant to antimicrobial agents, including carbapenems, fluoroquinolones, and aminoglycosides.

Entities:  

Year:  2013        PMID: 23868126      PMCID: PMC3715668          DOI: 10.1128/genomeA.00476-13

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Acinetobacter baumannii often causes infections in hospitalized immunocompromised patients (1). A. baumannii strains belonging to international clone II (IC2)/sequence type 2 (ST2), the most prevalent epidemic lineage, are associated with multidrug resistance and often cause nosocomial outbreaks (2). Since 2000, carbapenem-resistant and multidrug-resistant A. baumannii strains have emerged and their prevalence has increased worldwide. In some countries, carbapenem-resistant strains have reached a prevalence of >50%, becoming a serious public health threat (3). According to national surveillance data from Japan Nosocomial Infections Surveillance (JANIS) conducted by the Ministry of Health, Labour and Welfare (http://www.nih-janis.jp/english/), carbapenem resistance among Acinetobacter spp. in Japan remains much lower than in other countries (approximately 2% of imipenem resistance in Japan in 2012) (S. Suzuki, unpublished data). However, the prevalence tends to increase gradually, and nosocomial outbreaks of A. baumannii IC2 infections have occasionally occurred in Japan. To date, whole-genome sequences of A. baumannii strains isolated in Japan have not been available in GenBank. In this report, we announce the availability of the draft genome sequences of A. baumannii MRY09-0642, MRY10-0558, and MRY12-0277, which caused nosocomial outbreaks in geographically different medical institutions in Japan in 2008, 2010, and 2012, respectively. These isolates were classified as IC2 by multilocus sequence typing (4), whereas they showed distinct ApaI fragment patterns in pulsed-field gel electrophoresis. Whole-genome shotgun (WGS) sequencing of the A. baumannii strains was performed using the Roche 454 pyrosequencing platform (500-bp insert size). Reads were assembled with Newbler assembler version 2.3 (Roche), using A. baumannii Taiwanese strain MDR-TJ (5) as the reference. The draft genome sequences of A. baumannii MRY09-0642, MRY10-0558, and MRY12-0277 consist of 147, 77, and 106 contigs, respectively, yielding total sequences for each strain of 3,746,543, 3,782,742, and 3,829,745 bp, with N50 contig sizes of 64,650, 164,570, and 91,207 bp, respectively. Their mean G+C content is 39.0% ± 0.1%. A total of 3,645, 3,604, and 3,735 coding genes for MRY09-0642, MRY10-0558, and MRY12-0277, respectively, were detected by the RAST server (http://rast.nmpdr.org) (6). Acquired antimicrobial resistance genes in the WGS data were identified using a Web-based tool, ResFinder version 1.3 (http://cge.cbs.dtu.dk/services/ResFinder/) (7). A. baumannii MRY09-0642, MRY10-0558, and MRY12-0277 carry OXA-51-like β-lactamase genes, which predominantly confer carbapenem resistance in A. baumannii (8), found as blaOXA-82 in contig 00088, blaOXA-254 in contig 00034, and blaOXA-66 in contig 00056, respectively. A more-detailed report of the drug resistance and virulence phenotypes of these three A. baumannii strains will be included in a future publication. Access to these genome sequences and their comparative analyses with other epidemic and nonepidemic strains will facilitate additional comprehensive bioinformatics and phylogenetic analyses, thus expanding our understanding of the global public health problem caused by this nosocomial pathogen.

Nucleotide sequence accession numbers.

These WGS projects have been deposited at DDBJ/EMBL/GenBank under the accession no. BASA00000000, BASB00000000, and BASC00000000. The versions described in this report are the first versions, accession no. BASA01000000, BASB01000000, and BASC01000000 for A. baumannii strains MRY09-0642, MRY10-0558, and MRY12-0277, respectively.
  8 in total

1.  Differences in phenotypic and genotypic traits against antimicrobial agents between Acinetobacter baumannii and Acinetobacter genomic species 13TU.

Authors:  Jung Hoon Lee; Chul Hee Choi; Hee Young Kang; Ji Young Lee; Jungmin Kim; Yoo Chul Lee; Sung Yong Seol; Dong Taek Cho; Kun Woo Kim; Do Young Song; Je Chul Lee
Journal:  J Antimicrob Chemother       Date:  2007-03-05       Impact factor: 5.790

2.  Genome sequence of Acinetobacter baumannii MDR-TJ.

Authors:  Feng Gao; Yue Wang; Yan-Jie Liu; Xiao-Meng Wu; Xing Lv; Yi-Ru Gan; Shi-Duo Song; He Huang
Journal:  J Bacteriol       Date:  2011-03-11       Impact factor: 3.490

3.  The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool.

Authors:  Laure Diancourt; Virginie Passet; Alexandr Nemec; Lenie Dijkshoorn; Sylvain Brisse
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

4.  Rapid discrimination of Acinetobacter baumannii international clone II lineage by pyrosequencing SNP analyses of bla(OXA-51-like) genes.

Authors:  Mari Matsui; Satowa Suzuki; Masato Suzuki; Yoshichika Arakawa; Keigo Shibayama
Journal:  J Microbiol Methods       Date:  2013-05-26       Impact factor: 2.363

Review 5.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

6.  Identification of acquired antimicrobial resistance genes.

Authors:  Ea Zankari; Henrik Hasman; Salvatore Cosentino; Martin Vestergaard; Simon Rasmussen; Ole Lund; Frank M Aarestrup; Mette Voldby Larsen
Journal:  J Antimicrob Chemother       Date:  2012-07-10       Impact factor: 5.790

7.  Communicating trends in resistance using a drug resistance index.

Authors:  Ramanan Laxminarayan; Keith P Klugman
Journal:  BMJ Open       Date:  2011-11-14       Impact factor: 2.692

8.  The RAST Server: rapid annotations using subsystems technology.

Authors:  Ramy K Aziz; Daniela Bartels; Aaron A Best; Matthew DeJongh; Terrence Disz; Robert A Edwards; Kevin Formsma; Svetlana Gerdes; Elizabeth M Glass; Michael Kubal; Folker Meyer; Gary J Olsen; Robert Olson; Andrei L Osterman; Ross A Overbeek; Leslie K McNeil; Daniel Paarmann; Tobias Paczian; Bruce Parrello; Gordon D Pusch; Claudia Reich; Rick Stevens; Olga Vassieva; Veronika Vonstein; Andreas Wilke; Olga Zagnitko
Journal:  BMC Genomics       Date:  2008-02-08       Impact factor: 3.969

  8 in total
  3 in total

1.  Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.

Authors:  Kortine Annina Kleinheinz; Katrine Grimstrup Joensen; Mette Voldby Larsen
Journal:  Bacteriophage       Date:  2014-01-22

2.  An outbreak of blaOXA-51-like- and blaOXA-66-positive Acinetobacter baumannii ST208 in the emergency intensive care unit.

Authors:  Satomi Asai; Kazuo Umezawa; Hideo Iwashita; Toshio Ohshima; Maya Ohashi; Mika Sasaki; Hideki Hayashi; Mari Matsui; Keigo Shibayama; Sadaki Inokuchi; Hayato Miyachi
Journal:  J Med Microbiol       Date:  2014-08-20       Impact factor: 2.472

3.  Transmission electron microscopic morphological study and flow cytometric viability assessment of Acinetobacter baumannii susceptible to Musca domestica cecropin.

Authors:  Shuiqing Gui; Rongjiang Li; Yongwen Feng; Sanming Wang
Journal:  ScientificWorldJournal       Date:  2014-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.